StockNews.AI
XRAY
StockNews.AI
71 days

INVESTOR NOTICE: Kaskela Law LLC Announces Investigation of Dentsply Sirona Inc. and Encourages Long-Term Dentsply Investors to Contact the Firm - XRAY

1. Kaskela Law investigates potential breach of fiduciary duty related to XRAY. 2. An amended securities fraud complaint has been filed against Dentsply. 3. The complaint alleges misrepresentation of financial results from June 2021 to November 2022. 4. XRAY's stock price dropped from $48 to $30 during the alleged misconduct period. 5. The investigation examines possible violations by Dentsply's board of directors.

4m saved
Insight
Article

FAQ

Why Bearish?

Recent investigations and lawsuits tend to generate distrust, impacting stock prices negatively. Historical examples include cases like Theranos and Luckin Coffee, where legal issues considerably affected share values.

How important is it?

The legal investigation into fiduciary breaches could deter investor confidence and negatively affect market perception. As it's related to financial misconduct, the implications may be significant for current and potential investors.

Why Short Term?

Legal investigations often have immediate but temporary impacts on stock prices. Similar past instances have led to swift market reactions, lasting until resolutions unfold.

Related Companies

N/A
Kaskela Law LLC announces that it is investigating potential breach of fiduciary duty claims concerning Dentsply Sirona Inc. (NASDAQ:XRAY) ("Dentsply") on behalf of the company's long-term investors.Click here to receive additional information about your legal rights and options: https://kaskelalaw.com/case/dentsply-sirona/Recently an amended securities fraud complaint was filed against Dentsply on behalf of investors who purchased shares of the company's stock between June 9, 2021 and November 13, 2022. According to the complaint, during that time period Dentsply and certain of the company's senior executive officers materially misrepresented the company's financial and operational results for the second half of fiscal 2021 by engaging in "channel stuffing," "off-book arrangements," "enhanced incentives" to end-users, and the delayed issuance of rebate checks.The complaint further details how, through a series of partial disclosures between April 2022 and November 2022 - which included resignations, terminations, and an internal investigation by the company's Audit and Finance Committee - investors slowly learned the truth about the company's prior misrepresentations and suffered economic damages as a result therefrom. During that time period, the company's stock price declined in value from approximately $48.00 per share in April 2022 to approximately $30.00 per share in November 2022.The investigation seeks to determine whether the members of Dentsply's board of directors violated the securities laws and/or breached their fiduciary duties in connection with the above alleged misconduct and disclosures.Current Dentsply stockholders who purchased or acquired shares of XRAY stock prior to April 11, 2022 are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 - 0750 for additional information about this investigation and their legal rights and options.Alternatively, investors may submit their information to the firm by clicking on the following link (or by copying and pasting the link into your browser):https://kaskelalaw.com/case/dentsply-sirona/Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation on a contingent basis. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.CONTACT:KASKELA LAW LLCD. Seamus Kaskela, Esq. ([email protected]) Adrienne Bell, Esq. ([email protected]) 18 Campus Blvd., Suite 100 Newtown Square, PA 19073 (888) 715 - 1740 (484) 229 - 0750 www.kaskelalaw.comThis notice may constitute attorney advertising in certain jurisdictions.SOURCE: Kaskela Law LLC

Related News